Hepatitis B vaccine adverse events: citations
[2012 Feb] Hep B Vaccine Damages The Liver It Is Supposed To Protect – GreenMedInfo
 Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years This study found statistically significant evidence to suggest that boys in United States who were vaccinated with the triple series Hepatitis B vaccine, during the time period in which vaccines were manufactured with thimerosal, were more susceptible to developmental disability than were unvaccinated boys.
[2008 Sept] Carolyn Gallagher a; Melody Goodman a. Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years This study found statistically significant evidence to suggest that boys in United States who were vaccinated with the triple series Hepatitis B vaccine, during the time period in which vaccines were manufactured with thimerosal, were more susceptible to developmental disability than were unvaccinated boys.
Neonatal Deaths After Hepatitis B Vaccine The Vaccine Adverse Event Reporting System, 1991-1998 Manette T. Niu, MD; Marcel E. Salive, MD, MPH; Susan S. Ellenberg, PhD
Allergy reactions to gelatin & neomycin (journal articles)
Allen MB, et al. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax. 1993 May;48(5):580-1. No abstract available.PMID: 8322254; UI: 93310736.
Berkman N, et al. [Bilateral neuro-papillitis after hepatitis B vaccination]. Presse Med. 1996 Sep 28;25(28):1301. French. No abstract available.PMID: 8949792; UI: 97107044
N. [A case of segmentary unilateral occlusion of the central retinal vein
following hepatitis B vaccination]. Presse Med. 1997 Apr 26;26(14):670. French. No
abstract available.PMID: 9180888; UI: 97324783.
Bentsi-Enchill A. Adverse events following the administration of hepatitis B vaccines. Can Commun Dis Rep. 1992 Apr 17;18(7):49-53. English; French. No abstract available.PMID: 1291014; UI: 93177423.
D, et al. A new case of reactive arthritis after hepatitis B vaccination. Clin
Exp Rheumatol. 1993 Mar-Apr;11(2):215. No abstract available.PMID: 8508565; UI: 93284771.
Biasi D, et al.[Rheumatological manifestations following hepatitis B vaccination. A report of 2 clinical cases]. Recenti Prog Med. 1994 Sep;85(9):438-40. Review. Italian. PMID: 7938876; UI: 95025084.
Biacabe B, et al. A case report of fluctuant sensorineural hearing loss after hepatitis B vaccination. Auris Nasus Larynx. 1997 Oct;24(4):357-60. PMID: 9352826; UI: 98012875.
Bourges JL, et al. [Multifocal placoid epitheliopathy and anti-hepatitis B vaccination]. J Fr Ophtalmol. 1998 Nov;21(9):696-700. French. PMID: 9894208; UI: 99111579.
Bonfils P, et al. [Fluctuant perception hearing loss after hepatitis B vaccine]. Ann Otolaryngol Chir Cervicofac. 1996;113(6):359-61. French. PMID: 9124778; UI: 97254004.
Brooks R, et al. Guillain-Barre syndrome following trivalent influenza vaccine in an elderly patient. Mt Sinai J Med. 1980 Mar-Apr;47(2):190-1. No abstract available.PMID: 6967162; UI: 80232515
Bracci M, et al. Polyarthritis associated with hepatitis B vaccination. Br J Rheumatol. 1997 Feb;36(2):300-1. No abstract available.PMID: 9133957; UI: 97279516
A, et al. Visual loss and eosinophilia after recombinant hepatitis B
vaccine. Lancet. 1993 Aug 28;342(8870):563-4. No abstract available.PMID: 8102709; UI:
Bui-Quang D, et al. [Cutaneous vasculitis after hepatitis B vaccination with recombinant vaccine in a renal transplant patient]. Presse Med. 1998 Sep 12;27(26):1321-3. French. PMID: 9779046; UI: 98452068.
Christau B, et al. [Reactive arthritis following vaccination against hepatitis B]. Ugeskr Laeger. 1987 Jul 6;149(28):1882. Danish. No abstract available.PMID: 3433400; UI: 88128088.
Green, C et al, "A Case of Hepatitis Related to Etretinate Therapy and Hepatitis B Vaccine", Dermatologica, 1991, 182(2):119-120.
David A Geier,
Mark R Geier MD PhD.
Chronic adverse reactions associated with hepatitis B vaccination.
The Annals of Pharmacotherapy 2002: Vol. 36,
No. 12, pp. 1970–1971.
In conclusion, our study demonstrates that adult HBV is statistically associated not only with acute neuropathy, neuritis, myelitis, vasculitis, thrombocytopenia, gastrointestinal disease, multiple sclerosis, and arthritis, but some of these patients go on to develop chronic adverse reactions that persist for at least 1 year following HBV. These types of chronic adverse reactions following adult HBV should be discussed with patients contemplating being immunized with HBV and should be included in the differential diagnosis of those who develop them following adult HBV.
Geier DA, Geier MR.
A one year followup of chronic arthritis following rubella and hepatitis B
vaccination based upon analysis of the Vaccine Adverse Events Reporting System
(VAERS) database. Clin Exp Rheumatol
2002 Nov-Dec;20(6):767-71. MedCon, Inc.,
Silver Spring, Maryland, USA.
OBJECTIVES: This analysis examined the incidence rate of chronic arthritis adverse reactions reported following adult rubella and hepatitis B vaccinations. In this analysis, etiologic mechanisms for chronic arthritis following adult rubella and hepatitis B vaccines were also explored. METHODS: The Vaccine Adverse Events Reporting System (VAERS) database was analyzed for the incidence rate of reported cases of chronic arthritis in comparison to Tetanus-diphtheria (Td) and tetanus toxoid adult vaccine control groups. RESULTS: Chronic arthritis adverse reactions following adult rubella vaccination were primarily reported in females (female/male ratio = 3.0), at about 45 years-old, and at a mean onset time of 10-11 days following vaccination. Chronic arthritis adverse reactions following adult hepatitis B vaccination were also primarily reported in females(female/male ratio = 3.5), at about 33 years-old, and with a mean onset time of 16 days following vaccination. The incidence rates of chronic arthritis following adult rubella and adult hepatitis B vaccinations were statistically significantly increased, by chi 2 analysis, in comparison to the adult vaccine control groups. The attributable risk of chronic arthritis following adult rubella vaccine ranged from 32 to 53 and from 5.1 to 9.0 following adult hepatitis B vaccine in comparison to the adult vaccine control groups. CONCLUSION: This study revealed that adult rubella and adult hepatitis B vaccines were statistically associated with chronic arthritis which persisted for at least one year. The etiology for these adverse reactions may involve autoimmune mechanisms. Furthermore, potential biases in the reporting rates of adverse reactions to VAERS were not observed. PMID: 12508767 [PubMed - in process]
S, Takahashi T, Nakayama S, Ohhara K, Ebihara I, Koide H, Ohno J.[A case
of membranoproliferative glomerulonephritis associated with hepatitis B (author's transl)]Nippon Jinzo Gakkai Shi. 1980 Jan;22(1):41-9. Japanese. No abstract
available.PMID: 7382161 [PubMed - indexed for MEDLINE]
Hall A, Kane M, Roure C, Meheus A. Multiple sclerosis and hepatitis B vaccine? Pubblicato su: Vaccine 1999 Jun 4;17(20-21):2473-5 London School of Hygiene and Tropical Medicine, UK. PMID: 10418891, UI: 99345232
Halsey NA, et al. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board. Pediatr Infect Dis J. 1999 Jan;18(1):23-4. Review. No abstract available.PMID: 9951975; UI: 99135446.
F, Altintas A, Saip S, Siva A. Hepatitis B vaccine
related-myelitis?Eur J Neurol. 2001 Nov;8(6):711-5.PMID: 11784358
[PubMed - indexed for MEDLINE]
Kerleau JM, et al. [Is hepatitis B vaccination a new cause of necrotizing vasculitis]? Rev Med Interne. 1997;18(6):491-2. French. No abstract available.PMID: 9247052; UI: 97390000.
Kakar A, Sethi PK. Guillain Barre syndrome associated with hepatitis B vaccination.Indian J Pediatr. 1997 Sep-Oct;64(5):710-2. No abstract available.PMID: 10771907 [PubMed - indexed for MEDLINE]
TM, et al. Transient hepatitis B antigenemia in hemodialysis patients
following hepatitis B vaccination. ANNA J. 1996 Jun;23(3):331, 337. No abstract
available.PMID: 8716993; UI: 96356647. [See
Kaplanski G, et al. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):758-9. No abstract available.PMID: 7608688; UI: 95332874.
Korman SH. Thrombocytopenic purpura during the incubation of hepatitis B. Acta Paediatr Scand. 1991 Oct;80(10):975-6. PMID: 1755310; UI: 92095079
Kerleau JM, et al. [Is hepatitis B vaccination a new cause of necrotizing vasculitis]? Rev Med Interne. 1997;18(6):491-2. French. No abstract available.PMID: 9247052; UI: 97390000.
Konstantinou D, Paschalis C, Maraziotis T, Dimopoulos P, Bassaris H, Skoutelis A. Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient. Clin Infect Dis. 2001 Nov 15;33(10):1772-3.PMID: 11595974 [PubMed - indexed for MEDLINE]
Lasheras Carbajo MD, et al. [See Related Articles] [A case of intense cytolysis following the administration of a hepatitis B vaccine]. Rev Clin Esp. 1999 Jan;199(1):49-50. Review. Spanish. No abstract available.PMID: 10089783; UI: 99189653.
Hello C, et al. Suspected hepatitis B vaccination related vasculitis. J
Rheumatol. 1999 Jan;26(1):191-4. Review. PMID: 9918261; UI: 99114793.
S. Laoussadi, V. Sayag-Boukris, C.-J. Menkes, André Kahan. Department of Rheumatology A, Cochin Hospital, Paris V University, Paris,France. HBV vaccination may induce hypersensitivity and autoimmune reactions in susceptible individuals and healthy
Subjects. Seven patients (4 F, 3 M; mean age 35 ± 10 yrs), developed severe rheumatic disorders after the first (4) or the third (3) injection of HBV vaccine. Before HBV vaccination, one was a healthy subject and 6 were previously suffering from: eosinophilic fasciitis (1), systemic lupus (1), HLA B27 positive axial ankylosing spondylitis (2), sickle cell disease (1) and idiopathic cutaneous urticaria (1). The underlying disease was in remission induced by treatment (4 cases), including NSAIDs (2), corticosteroids (CS; 1), sulfasalazine (SZ; 2) and hydroxychloroquine (HC; 1) and in 3 cases there was no treatment. Fourteen days (mean) after vaccine injection, they developed rheumatic disorders including: 3 severe symetric polyarthritis fulfilling ARA RA criteria, associated in one case with vasculitis and 2 monoclonal IgM cryoglobulins. Two cases of oligoarthritis (one associated with palatine and laryngeal oedema, ocular sicca syndrome, hypereosinophilia, positive ANA, and C4 defect), 1 case of Sjögren syndrome, 1 severe systemic flare of lupus with arthritis, pleural effusion, vasculitis and a grade IIIa glomerulonephritis.
In all patients these disorders were controlled using prednisone therapy (0.3 to 1 mg/kg/day; 7) combined, according to the underlying rheumatic disease with HC (2), SZ (2), cyclophosphamide (1), azathioprine (1), methotrexate (1) and IV Ig (1). Six patients met a remission after 2 months to one year treatment, but they are still under treatment. In one patient, with eosinophilic fasciitis, a total recovery was observed after 7 years and he has stopped any treatment for 2 years.
Hepatitis B virus vaccination may induce severe reactions requiring the use of a long term treatment (mean period of time of 32.5 ± 24.8 months) in healthy subjects and in patients who suffer from autoimmune diseases and from ankylosing spondylitis or reactive arthritis, even if a complete remission has been already obtained. Abstract: 1186 November 10, 1998 Poster Session D: Miscellaneous Rheumatic Diseases 12:30-2:00 pm, Hall B1/C
Manna R, et al. Leukoencephalitis after recombinant hepatitis B vaccine. J Hepatol. 1996 Jun;24(6):764-5. No abstract available.PMID: 8835755; UI: 96432703.
J.F. Maillefert1, J. Sibilia2, E. Toussirot3, E. Vignon4, R. Juvin5, C. Piroth1, D. Wendling3, J.L. Kuntz2, C. Tavernier1, P. Gaudin5 Departments of Rheumatology; 1Dijon; 2Strasbourg; 3Besançon; 4Lyon; 5Grenoble, France
Aim: to obtain an overview of rheumatic disorders occurring after hepatitis B vaccination.
Methods: a questionnaire was sent to rheumatology departments in nine french hospitals. Criteria for entry were rheumatic complaints of one-week duration or more, occurrence during the 2 months following hepatitis B vaccination, no previously diagnosed rheumatic disease, exclusion of bacterial or viral reactive arthritis.
Results: 21 patients (18 women, 3 men; mean age = 30.7 years +/- 12.6 SD) were included. All received recombinant hepatitis B vaccine. The time interval between the vaccination and occurrence of complaints was one week or less for 10 patients, between one week and one month for 8 patients, between one and two months for 3 patients. In 9 patients, the next vaccinal dose was inoculated despite the complaints. The symptomatology worsened in 7 cases, and was not modified in one case (effects unknown for the last patient). The observed disorders were as follows: rheumatoid arthritis for 6 patients, systemic lupus erythematosus for 2, reactive arthritis for 5, polyarthralgia-myalgia-fatigue for 3, suspected or biopsy-proved vasculitis for 3, miscellaneous for 2. Conclusion: hepatitis B vaccination might be followed by various rheumatic conditions, and might trigger the onset of underlying inflammatory and/or auto-immune rheumatic diseases. However, a causal relation between hepatitis B vaccination and the observed rheumatic manifestations cannot be easily established. Further epidemiological works are needed to establish whether hepatitis B vaccination is associated or not with an incidence of rheumatic disorders higher than normal.
Marsaudon E, et al. [Meningeal reaction after vaccination against hepatitis B]. Presse Med. 1996 Oct 26;25(32):1561-2. French. No abstract available.PMID: 8952667; UI: 97110516.
F, et al. Nephrotic syndrome after recombinant hepatitis B vaccine.
Clin Nephrol. 1995 May;43(5):349. No abstract available.PMID: 7634556; UI:
Mader R, et al. Systemic vasculitis following influenza vaccination--report of 3 cases and literature review. J Rheumatol. 1993 Aug;20(8):1429-31. Review. PMID: 8230034; UI: 94046875.
F, et al. [Acute myelitis after vaccination against hepatitis B]. Presse Med.
1993 Dec 18;22(40):1997-8. French. PMID: 8127802; UI:
Maillefert JF, et al. Mental nerve neuropathy as a result of hepatitis B vaccination. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jun;83(6):663-4. PMID: 9195619; UI: 97339059.
Maillefert JF, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford). 1999 Oct;38(10):978-83. PMID: 10534549; UI: 20006401[See Related Articles]
Marsaudon E, et al. [Meningeal reaction after vaccination against hepatitis B]. Presse Med. 1996 Oct 26;25(32):1561-2. French. No abstract available. PMID: 8952667; UI: 97110516.
E, et al. Cryoglobulinemia after hepatitis B vaccination. N Engl J Med. 1996 Aug
1;335(5):355. No abstract available.PMID: 8668224; UI: 96283165.
Masse I, et al. [Hypersensitivity vasculitis after hepatitis B vaccination]. Presse Med. 1998 Jun 6;27(20):965-6. French. No abstract available.PMID: 9767839; UI: 98440953.
E, et al. Evans's syndrome triggered by recombinant hepatitis B vaccine. Clin
Infect Dis. 1992 Dec;15(6):1051. No abstract available.PMID: 1457642; UI: 93091042.
Meyboom RH, et al. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet. 1995 Jun 24;345(8965):1638. No abstract available.PMID: 7632294; UI: 95302878.
S, et al. Eosinophilia after intradermal hepatitis B vaccination. Lancet. 1993
Oct 16;342(8877):998. No abstract available.PMID: 8105253; UI: 94018194.
Neau D, et al. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases. Scand J Infect Dis. 1998;30(2):115-8. PMID: 9730294; UI: 98398062.
Nadler JP. Multiple sclerosis and hepatitis B vaccination. Clin Infect Dis. 1993 Nov;17(5):928-9. No abstract available. PMID: 8286645; UI: 94114816.
Noel I, et al. Hypersensitivity to thiomersal in hepatitis B vaccine. Lancet. 1991 Sep 14;338(8768):705. No abstract available.PMID: 1679511; UI: 91359780.
Noble JP, et al. [Skin diseases related to hepatitis B vaccine]. Gastroenterol Clin Biol. 1997;21(1):87. French. No abstract available.PMID: 9091400; UI: 97226853.
No authors listed] [See Related Artices] Report of the working group on the possible relationship between hepatitis B vaccination and the chronic fatigue syndrome. CMAJ. 1993 Aug 1;149(3):314-9. English; French. No abstract available.PMID: 8339178; UI: 93338559.
MP, et al. Sudden hearing loss in childhood consequent to hepatitis B
vaccination: a case report. Ann N Y Acad Sci. 1997 Dec 29;830:319-21. No abstract
available.PMID: 9616691; UI: 98279663.
Ozdemir S, et al. Nephrotic syndrome associated with recombinant hepatitis B vaccination: a causal relationship or just a mere association? Nephrol Dial Transplant. 1998 Jul;13(7):1888-9. No abstract available.PMID: 9681759; U
Pemberton MN, Sloan P, Thakker NS. Oral lichenoid lesions after hepatitis B vaccination.:Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 Jun;89(6):717-719 PMID: 10846126
Petousis-Harris H, et al. Hepatitis B vaccination and diabetes. N Z Med J. 1999 Aug 13;112(1093):303-4. No abstract available.PMID: 10493435; UI: 99421178.
Pennesi M, Torre G, Del Santo M, Sonzogni A.Glomerulonephritis after recombinant hepatitis B vaccine.Pediatr Infect Dis J. 2002 Feb;21(2):172-3.PMID: 11840090 [PubMed - indexed for MEDLINE]
H, et al. [Acute pericarditis after vaccination against hepatitis B: a rare effect to
be known]. Rev Med Interne. 1997;18(8):675-6. French. No abstract available.PMID: 9365747;
Poullin P, et al. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet. 1994 Nov 5;344(8932):1293. No abstract available.PMID: 7967998; UI: 95057573.
Pope JE, et al. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol. 1998 Sep;25(9):1687-93. PMID: 9733447; UI: 98402283.
E, Schroder JM, Krismann M, Malin JP. Inflammatory polyradiculoneuropathy
with spinal cord involvement and lethal outcome after hepatitis B vaccination.
Neurologische Klinik, BG-Kliniken Bergmannsheil, Ruhr-Universitat, Burkle-de-la-Camp-Platz 1, 44789, Bochum, Germany
J Neurol Sci 2001 May 1;186(1-2):81-5
We report on a 36-year-old man who developed an inflammatory polyradiculoneuropathy similar to Guillain-Barre syndrome 9 days after hepatitis B vaccination. Extensive immunotherapy including immunoglobulins, steroids, plasmapheresis, cyclophosphamide and methotrexate did not stop the progressive course of the disease and the patient died 4 months later due to multiorgan failure with septic shock symptoms and adult respiratory distress syndrome (ARDS).The neuropathological investigation showed severe axonal loss with mild demyelination of peripheral nerves and mononuclear cell infiltrates, predominantly T-lymphocytes, in nerve roots and spinal ganglia. In addition, there were unusual, perivascular and parenchymal lymphocytic cell infiltrates in the grey matter, especially the anterior horns of the spinal cord. The temporal relationship to hepatitis B vaccination, the strong increase of HBs-antibodies within 3 weeks after vaccination, and the presumptive immune mediated pathology of this disorder suggest a possible etiologic link with hepatitis B vaccine. ------------------------
M, et al. A case of Churg-Strauss vasculitis after hepatitis B vaccination. Ann
Rheum Dis. 1998 Apr;57(4):256-7. No abstract available.PMID: 9709187; UI: 98374849.
Vautier G, et al. Acute sero-positive rheumatoid arthritis occurring after hepatitis vaccination. Br J Rheumatol. 1994 Oct;33(10):991. No abstract available.PMID: 7921766; UI: 95006007.
Voigt U, Baum U, Behrendt W, Hegemann S, Terborg C, Strobel J. [Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever] Klin Monatsbl Augenheilkd. 2001 Oct;218(10):688-90. German.PMID: 11706386 [PubMed - indexed for MEDLINE]
Waugh MA. [See Related Articles] Acute hepatitis B infection after vaccination. Lancet. 1995 Jan 28;345(8944):262; discussion 262-3. No abstract available.PMID: 7823746; UI: 95124109.
NA, "The Risk of AIDS after Hepatitis Vaccination," JAMA, 1985 May 24-31; 253(20):2960-2961.
Francis, DP, et al, "The Safety of the Hepatitis B Vaccine. Inactivation of the AIDS virus During Routine Manufacture", JAMA, 1986 Aug 15; 256(7): 869-872.
Kato, S et al, "Hepatitis B Vaccination and AIDS," JAMA, 1985 Jul 5; 254(1):53.
Macek, C, "AIDS Transmission: What about the Hepatitis B Vaccine?", JAMA, 1983 Feb 11; 249(6):685-686.
Papaevangelou, G et al, "Risk of AIDS in Recipients of Hepatitis B Vaccine", NEJM, 1985 Feb 7; 312(6):376-377.
Scheier, R, Hepatitis vaccine: the Danger of AIDS Transmission, Z Hautkr, 1984 Apr 15; 59(8):502-506.
Schwartz, AM, et al, "Hepatitis Vaccine and the Acquired Immunodeficiency Syndrome", 1983, JAMA, Oct: 99(4):567-568.
Sacks, H S, et al, "Should the Risk of Acquired Immunodeficiency Syndrome deter Hepatitis B Vaccination?" A Decision Analysis." JAMA, 1984 Dec 28; 252(24): 3375-3377.
Taubman, L B, et al, "The Question of Possible Relationship Between Hepatitis B Vaccine and AIDS", AM J Med, 1984 Apr; 76(4): A 59.